Form 4: Intuitive Surgical Director Reports Future Stock Transactions

Intuitive Surgical Director Gary S. Guthart reported future vesting and tax-related disposition of company stock and performance units under a Rule 10b5-1 plan.

Summary

• Gary S. Guthart, a Director of Intuitive Surgical Inc. (ISRG), reported planned transactions for February 26, 2026.
• These transactions include the acquisition of 4,960 shares of Common Stock at $0.0 upon RSU vesting.
• A disposal of 2,460 shares of Common Stock at $506.17 is planned to cover statutory tax withholding requirements.
• Another acquisition of 3,433 shares of Common Stock at $0.0 is planned upon RSU vesting.
• A further disposal of 1,703 shares of Common Stock at $506.17 is planned for tax withholding.
• 8,778 Performance Stock Units (PSUs) granted on February 28, 2023, for which performance criteria have been achieved, are set to vest on February 28, 2026.
• The reporting person will beneficially own 9,981 shares directly after the first set of transactions and 10,954 shares directly after the second set of transactions.
• Indirect beneficial ownership includes 15,720 shares each in a Trust FBO Daughter and a Trust FBO Son, and 1,231,890 shares by a general Trust.
• Restricted Stock Units (RSUs) vest 25% per year over a four-year period, converting to common stock on a one-for-one basis upon vesting.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting the successful achievement of performance criteria for PSUs and the routine execution of executive compensation plans, which are generally positive for management alignment.

Positives

• The achievement of performance criteria for 8,778 Performance Stock Units (PSUs) indicates strong company or individual performance.
• The vesting of Restricted Stock Units (RSUs) and PSUs represents a routine component of executive compensation, aligning management interests with shareholder value.

Future Outlook

The filing indicates the future vesting of 8,778 Performance Stock Units (PSUs) on February 28, 2026, contingent on the reporting person's continuous service to the Issuer. This reflects a pre-determined compensation schedule.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing executive stock transactions, particularly those related to RSU and PSU vesting and subsequent tax-related dispositions, are routine occurrences in publicly traded companies. These transactions are typically pre-scheduled under Rule 10b5-1 plans, reflecting standard executive compensation practices rather than discretionary trading based on new material information. This specific filing for Intuitive Surgical Inc. aligns with common corporate governance and compensation structures in the medical device and technology sectors.

Related Party Transactions

• Indirect beneficial ownership is reported through trusts for the reporting person's daughter, son, and a general trust, which is a common arrangement for executive estate planning and compensation.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation and tax management, which is generally expected and does not indicate a significant shift in company strategy or financial health.
• Employees: No direct impact on general employees is indicated by this filing.
• Management: The vesting of stock units reinforces compensation and aligns management's long-term interests with company performance.

Next Steps

• The 8,778 Performance Stock Units (PSUs) are scheduled to vest on February 28, 2026, subject to continuous service.

Key Dates

Recommendation

This Form 4 filing details routine, pre-planned executive compensation transactions (vesting of RSUs and PSUs, and subsequent tax-related share dispositions). It does not contain new material information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transactions are expected and reflect standard corporate governance and compensation practices, thus a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a 'buy' or 'sell' decision.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance Stock Units, Stock Vesting, Rule 10b5-1